Alberta Investment Management Corp (AIMCo)’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-52,100
Closed -$676K 966
2021
Q2
$676K Buy
52,100
+2,400
+5% +$30.6K 0.01% 831
2021
Q1
$646K Sell
49,700
-26,800
-35% -$389K 0.01% 737
2020
Q4
$1.05M Buy
76,500
+400
+0.5% +$5.82K 0.01% 655
2020
Q3
$1.12M Buy
+76,100
New +$1.1M 0.01% 641

Other funds holding AUPH

Alberta Investment Management Corp (AIMCo)'s AUPH Position: Q3 2021 in Review

Alberta Investment Management Corp (AIMCo) sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2021, closing a stake of 52,100 shares — an estimated $676K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in AUPH in Q3 2020 and held it in 4 quarters. The position peaked at $1.12M in Q3 2020. 166 funds tracked by Wall St. Rank hold AUPH as of Q3 2021.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Aurinia Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 52,100 Aurinia Pharmaceuticals shares in Q3 2021, an estimated $676K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Aurinia Pharmaceuticals in Q3 2020 and held it in 4 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Aurinia Pharmaceuticals position peaked at $1.12M in Q3 2020.
  • 166 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2021.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2021, filed 15 Nov 2021.